systematic_review
    2006

    Vitamin K2 and bone health: a systematic review

    Iwamoto, I., Kosha, S., Noguchi, S.

    Published in Nutrition Research

    Abstract

    Systematic review of menaquinone effects on bone mineral density and fracture risk

    Methodology

    Systematic review of published clinical trials of vitamin K2 supplementation reporting bone mineral density, bone turnover markers and fracture outcomes.

    Key Findings

    Review of vitamin K2 (menaquinone) trials, dominated by Japanese studies of high-dose MK-4 (45 mg/day), reported improved bone mineral density maintenance and reduced vertebral and non-vertebral fracture rates in postmenopausal and osteoporotic women, with effects on bone quality via osteocalcin carboxylation rather than density alone.

    Conclusions

    High-dose vitamin K2 shows fracture-reduction signals in Japanese osteoporosis trials, but the evidence is geographically narrow and later large Western trials have been less convincing.

    Limitations

    Included trials mostly from one country with small samples and methodological weaknesses, publication bias likely, pharmacological MK-4 doses far exceed dietary intake, and subsequent large trials did not replicate the fracture benefit.

    Supplements Studied

    Vitamin K2
    Vitamin

    Review of vitamin K2 (menaquinone) trials, dominated by Japanese studies of high-dose MK-4 (45 mg/day), reported improved bone mineral density maintenance and reduced vertebral and non-vertebral fracture rates in postmenopausal and osteoporotic women, with effects on bone quality via osteocalcin carboxylation rather than density alone.

    Vitamin K1
    Vitamin

    Review of vitamin K2 (menaquinone) trials, dominated by Japanese studies of high-dose MK-4 (45 mg/day), reported improved bone mineral density maintenance and reduced vertebral and non-vertebral fracture rates in postmenopausal and osteoporotic women, with effects on bone quality via osteocalcin carboxylation rather than density alone.

    Outcomes Measured

    Review of vitamin K2 (menaquinone) trials, dominated by Japanese studies of high-dose MK-4 (45 mg/day), reported improved bone mineral density maintenance and reduced vertebral and non-vertebral fracture rates in postmenopausal and osteoporotic women, with effects on bone quality via osteocalcin carboxylation rather than density alone.

    Study Details

    Year:2006
    Quality Score:5/10

    Access Study

    Disclosures

    Funding

    Academic institutional funding

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.